AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30209645
Drug: Tablet-based information
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet-based information communication technology early intervention application
Trial: 30209645
Drug: Therapy-as-usual
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy-as-usual
Trial: 26242767
Drug: Insulin degludec/liraglutide
RxNorm normalized name: INSULIN DEGLUDEC/LIRAGLUTIDE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin degludec/liraglutide (Xultophy®)
Trial: 17227978
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with 6 cycles of gemcitabine on days 1, 8, and 15 every 4 weeks (n = 179)
Trial: 15472185
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (1200 mg calcium carbonate)
Trial: 7889010
Drug: Intensive antileukaemic
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive antileukaemic therapy (vincristine, prednisone, daunorubicin, cyclophosphamide, Ara C, asparaginase)
Trial: 3605674
Drug: Caudal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal morphine (0.5 mg/ml, 0.1 mg/kg)
Trial: 3605674
Drug: Caudal bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal bupivacaine (0.25%, 1 ml/kg)
Trial: 3605674
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine (control group)
Trial: 23129544
Drug: High-dose (HD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (HD) ablation
Trial: 23129544
Drug: Low-dose (LD)
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose (LD) ablation
Trial: 21959624
Drug: OxyContin (Oxycodone)
RxNorm normalized name: Oxycontin
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: OxyContin (Oxycodone) injections
Trial: 12592328
Drug: HuM195 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HuM195 at a dose of 12 mg/m(2)
Trial: 12592328
Drug: HuM195 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HuM195 at a dose of 36 mg/m(2)
Trial: 12592328
Drug: HuM195 (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HuM195 (both doses)
Trial: 10962963
Drug: Neutralised lignocaine-epinephrine
RxNorm normalized name: epinephrine / lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutralised lignocaine-epinephrine (1%, 5 microgram/ml) with 1.0 ml sodium bicarbonate (8.4 g/l) added to 10 ml lignocaine-epinephrine
Trial: 24394578
Drug: 60mg iron,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60mg iron, 500mg folic acid, 20,000 IU vitamin A, and 60mg vitamin C weekly for 5 weeks
Trial: 24394578
Drug: 60mg iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60mg iron and 250mg folic acid weekly for 5 weeks
Trial: 6464191
Drug: Oltipraz 1
RxNorm normalized name: Oltipraz
DrugBank: Oltipraz (DB12539)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oltipraz 1 X 25 mg/kg body weight
Trial: 6464191
Drug: Oltipraz 1
RxNorm normalized name: Oltipraz
DrugBank: Oltipraz (DB12539)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oltipraz 1 X 35 mg/kg body weight
Trial: 6464191
Drug: Oltipraz 2
RxNorm normalized name: Oltipraz
DrugBank: Oltipraz (DB12539)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oltipraz 2 X 20 mg/kg body weight
Trial: 6464191
Drug: Praziquantel 2
RxNorm normalized name: praziquantel 23 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel 2 X 30 mg/kg body weight
Trial: 30718072
Drug: Ramucirumab (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramucirumab (8 mg/kg) plus cisplatin (80 mg/m2) and capecitabine (1000 mg/m2, twice daily for 14 days) every 21 days.
Trial: 30718072
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus cisplatin (80 mg/m2) and capecitabine (1000 mg/m2, twice daily for 14 days) every 21 days.
Trial: 30718072
Drug: Ramucirumab (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramucirumab (8 mg/kg) plus cisplatin and capecitabine.
Trial: 2645756
Drug: Benazepril 20
RxNorm normalized name: benazepril 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benazepril 20 mg once daily
Trial: 15775795
Drug: Chlorthalidone 12.5
RxNorm normalized name: chlorthalidone 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 12.5 mg once daily
Trial: 12175274
Drug: PNCRM7 (PrevnarTM1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PNCRM7 (PrevnarTM1) vaccine
Trial: 2207950
Drug: Correspondence weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Correspondence weight control program with weekly homework, interim weigh-ins, and participation deposits
Trial: 344085
Drug: Trancopal 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trancopal 400 mg
Trial: 28511688
Drug: Preconception supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preconception supplements containing Folic Acid, Iron and Folic Acid (IFA), or Multiple Micronutrients
Trial: 28511688
Drug: Prenatal IFA
RxNorm normalized name: Ardisia crenata root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenatal IFA supplements for daily consumption through delivery
Trial: 28511688
Drug: Preconception supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preconception supplements
Trial: 21804439
Drug: Manufacturers' guidelines
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manufacturers' guidelines (cases rinsed with multipurpose solution and air dried)
Trial: 21804439
Drug: Alternative cleaning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative cleaning regimen (cases rubbed, rinsed with solution, tissue wiped, and air-dried face down)
Trial: 17178974
Drug: Nifedipine gastrointestinal
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine gastrointestinal therapeutic system (30 to 60 mg per day)
Trial: 9167505
Drug: Sertindole 24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertindole 24 mg/day
Trial: 8064705
Drug: Controlled-release, 10-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release, 10-mg pessary
Trial: 8064705
Drug: Low-dose gel,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose gel, 2.5-mg doses
Trial: 2663165
Drug: Piroxicam 0.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam 0.5% gel
Trial: 2663165
Drug: Diclofenac 1.16%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 1.16% gel
Trial: 31068954
Drug: COBRA therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COBRA therapy (prednisone 60 mg, methotrexate, sulfasalazine), n = 14
Trial: 31068954
Drug: COBRA-light therapy
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COBRA-light therapy (prednisone 30 mg, methotrexate), n = 21
Trial: 20696480
Drug: Cognitive behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behaviour therapy (CBT) for preventing depression
Trial: 12324668
Drug: Daily rhDNase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily rhDNase
Trial: 11171465
Drug: Propofol (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (target dose 5 micrograms.ml‐1 in 5 min)
Trial: 3467975
Drug: Citalopram 40
RxNorm normalized name: citalopram 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 40 mg (9 nights)
Trial: 3467975
Drug: Amitriptyline 75
RxNorm normalized name: amitriptyline 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 75 mg (9 nights)
Trial: 20580541
Drug: Low-dose arachidonic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose arachidonic acid (80 mg ARA daily for 3 weeks)
Trial: 17981455
Drug: Diclofenac and
RxNorm normalized name: diclofenac and antiinfectives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac and paracetamol
Trial: 8740720
Drug: Vinorelbine 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinorelbine 30 mg/m2 followed by Taxol 120 mg/m2 (V/T sequence)
Trial: 8740720
Drug: Taxol 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taxol 120 mg/m2 followed by Vinorelbine 30 mg/m2 (T/V sequence)
Trial: 1930697
Drug: Oral B
RxNorm normalized name: bran ORAL BOX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral B 35 manual brush
Trial: 29728394
Drug: Genetically determined
RxNorm normalized name: Burosumab (genetical recombination)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genetically determined CETP concentration increase of 1 µg/mL
Trial: 24473774
Drug: Standard-risk acute
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-risk acute lymphoblastic leukemia (SR-ALL) therapy
Trial: 19946860
Drug: Depot form
RxNorm normalized name: Primoteston Depot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depot form of pre-randomisation drug
Trial: 16244022
Drug: Small-dose (SD)
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small-dose (SD) bupivacaine (7.5 mg) with 5 mug of sufentanil
Trial: 16244022
Drug: Large-dose (LD)
RxNorm normalized name: Bos taurus large intestine preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large-dose (LD) bupivacaine (12.5 mg) with 5 mug of sufentanil
Trial: 12912857
Drug: Pharmacological agents
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological agents (sumatriptan, cisapride, erythromycin)
Trial: 10680107
Drug: Cisatracurium 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisatracurium 0.05 mg/kg (ED95)
Trial: 10680107
Drug: Cisatracurium 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisatracurium 0.1 mg/kg (2 x ED95)
Trial: 10680107
Drug: Cisatracurium 0.025
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisatracurium 0.025 mg/kg (0.5 x ED95)
Trial: 8765865
Drug: 8 ml
RxNorm normalized name: ethanol 0.8 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 ml 0.5% bupivacaine + 0.1 mg fentanyl (B+F group)
Trial: 8765865
Drug: 8 ml
RxNorm normalized name: ethanol 0.8 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 ml 0.5% bupivacaine + 2 ml saline (Bup group)
Trial: 30925948
Drug: Small-dose ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small-dose ropivacaine hydrochloride (1 mL) combined with fentanyl (10 µg)
Trial: 30925948
Drug: Large-dose ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large-dose ropivacaine hydrochloride (1.5 mL)
Trial: 30925948
Drug: Small-dose ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small-dose ropivacaine hydrochloride combined with fentanyl
Trial: 28493623
Drug: Aripiprazole (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole (15 mg over 8 days)
Trial: 22446565
Drug: Valacyclovir (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir (1.5 g twice daily for 18 weeks)
Trial: 20017356
Drug: Diclofenac 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 100 mg daily for 30 days
Trial: 20017356
Drug: Nimesulide 100
RxNorm normalized name: nimesulide 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide 100 mg BID for 30 days
Trial: 8689337
Drug: Intravenous ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ceftriaxone followed by oral cefixime
Trial: 6366811
Drug: Ordinary metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordinary metoprolol tablets (100 mg twice daily)
Trial: 6366811
Drug: Sustained-release metoprolol
RxNorm normalized name: metoprolol Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release metoprolol tablets (200 mg once daily)
Trial: 24418366
Drug: Intervention (depression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention (depression care management with treatment adherence support and interpersonal psychotherapy if desired)
Trial: 16260510
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (daily oral conjugated estrogen 0.625 mg plus medroxyprogesterone acetate 2.5 mg)
Trial: 9988782
Drug: Lower dose
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dose nutritional formula (Myer's Cocktail)
Trial: 9988782
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose nutritional I/V
Trial: 30851166
Drug: 10-day sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day sequential therapy (esomeprazole 40 mg, amoxicillin 1 g for 5 days, followed by esomeprazole 40 mg, clarithromycin 500 mg, and tinidazole 500 mg for 5 days)
Trial: 30851166
Drug: 14-day sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-day sequential therapy (esomeprazole 40 mg, amoxicillin 1 g for 7 days, followed by esomeprazole 40 mg, clarithromycin 500 mg, and tinidazole 500 mg for 7 days)
Trial: 25329822
Drug: Fentanyl (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (100 μg)
Trial: 21846796
Drug: Methyl selenocysteine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyl selenocysteine, single-dose, pharmacokinetics
Trial: 21846796
Drug: Selenomethionine, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenomethionine, 200 μg per day
Trial: 21846796
Drug: Selenized yeast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenized yeast (NPC agent)
Trial: 2560284
Drug: Enalapril (E),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (E), 10 mg/day for four weeks
Trial: 26743288
Drug: Different oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different oral hygiene maintenance programs
Trial: 26743288
Drug: Fixed orthodontic
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed orthodontic treatment with proper oral hygiene
Trial: 30203746
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of zoledronic acid
Trial: 16835383
Drug: CHOP followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CHOP followed by high-dose therapy with ASCT (4 cycles)
Trial: 16835383
Drug: CHOP followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CHOP followed by high-dose therapy with ASCT
Trial: 16835383
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with complete response at end of induction therapy
Trial: 12697371
Drug: 1200 mg/day
RxNorm normalized name: Rebetron, single dose 1200 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg/day elemental calcium and 800 IU/day vitamin D(3) supplementation
Trial: 11007833
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMWH) at 85 IU/kg b.w. (HHR)
Trial: 11007833
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMWH) at 45 IU/kg b.w. (LHR)
Trial: 9068336
Drug: Propofol induction
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol induction followed by a standard propofol infusion
Trial: 8437256
Drug: Initial treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial treatment (2-tablet quinolone treatment)
Trial: 8437256
Drug: Initial treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial treatment in premenopausal group
Trial: 8437256
Drug: Initial treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial treatment in postmenopausal group
Trial: 3093022
Drug: 10 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 micrograms 24R,25(OH)2D3 daily
Trial: 3093022
Drug: 24R,25(OH)2D3 treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24R,25(OH)2D3 treatment
Trial: 26862746
Drug: Low-abrasivity gel-to-foam
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-abrasivity gel-to-foam fluoride toothpaste (1,450 ppm NaF)
Trial: 26862746
Drug: Medium-abrasivity gel-to-foam
RxNorm normalized name: Medium-Chain Triglycerides
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-abrasivity gel-to-foam fluoride toothpaste (1,450 ppm NaF)
Trial: 24815910
Drug: Lisdexamfetamine dimesylate
RxNorm normalized name: Lisdexamfetamine Dimesylate
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine dimesylate (LDX) 30, 50, and 70 mg/day
Trial: 15878099
Drug: Accelerated fractionation
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated fractionation (AF) - 60.8 Gy in 32 fractions over 26 days, two fractions per day (1.8 Gy and 2.0 Gy) with a 6h gap, 1 week treatment gap after first 12 fractions.
Trial: 11955466
Drug: Repetitive transcranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repetitive transcranial magnetic stimulation (rTMS) - 10-20 treatments, 10 Hz, 110% motor threshold applied to the left dorsolateral prefrontal cortex for a total of 10,000-20,000 stimulations
Trial: 11955466
Drug: Electroconvulsive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroconvulsive therapy (ECT) - 4-12 treatments
Trial: 7634871
Drug: Theophylline 3
RxNorm normalized name: theophylline 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline 3 mg/kg
Trial: 7634871
Drug: Theophylline 6
RxNorm normalized name: theophylline 65 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline 6 mg/kg
Trial: 7634871
Drug: Theophylline 0
RxNorm normalized name: theophylline 0.4 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline 0 mg/kg (Control)
Trial: 2203382
Drug: Another procaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Another procaine preparation
Trial: 911591
Drug: 2% plain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% plain lignocaine 20 ml
Trial: 911591
Drug: 2% lignocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% lignocaine 20 ml with adrenaline 1:200,000
Trial: 25724021
Drug: Local anesthetic
RxNorm normalized name: Local anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthetic injection without acupuncture
Trial: 22299093
Drug: Three different
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three different types of implants from three different manufacturers
Trial: 22299093
Drug: Implants loaded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implants loaded after 8 weeks
Trial: 20555044
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol 400 microg every 6 h for a maximum of four doses
Trial: 20555044
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol 400 microg every 12 h for a maximum of four doses
Trial: 19040018
Drug: 1.0 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg/m2 bortezomib combined with dexamethasone
Trial: 19040018
Drug: 1.3 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.3 mg/m2 bortezomib combined with dexamethasone
Trial: 12154491
Drug: Topical treatment
RxNorm normalized name: Hongo Killer Treatment Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical treatment for athlete's foot
Trial: 12154491
Drug: Systemic treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic treatment for athlete's foot
Trial: 8916060
Drug: Aspirin 300
RxNorm normalized name: aspirin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 300 mg once daily for 2 weeks
Trial: 8916060
Drug: Ticlopidine 250
RxNorm normalized name: ticlopidine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine 250 mg twice daily for 2 weeks
Trial: 6356969
Drug: Intramuscular fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular fentanyl
Trial: 27480401
Drug: Oral micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral micronized progesterone (OMP) 400 mg/day
Trial: 22932279
Drug: Folate intake
RxNorm normalized name: folate
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folate intake from FA-containing prenatal supplement (750 μg/d) plus natural food folate (400 μg/d)
Trial: 12060478
Drug: Product containing
RxNorm normalized name: Product containing plant agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Product containing active ingredients to restore barrier function and modulate inflammatory response, applied twice a day for one month prior to UVA irradiation.
Trial: 2187822
Drug: d‐fenfluramine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d‐fenfluramine (15 mg)
Trial: 6138044
Drug: midazolam (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: midazolam (15 mg)
Trial: 31294589
Drug: Intensive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive group behavioral treatment (IGBT)
Trial: 28637047
Drug: Endobronchial valve
RxNorm normalized name: VALVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endobronchial valve treatment (EBV)